\u73fe\u5728\u3001\u4e16\u754c\u306e\u88fd\u85ac\u696d\u754c\u306f3\u3064\u306e\u6df1\u3044\u5909\u9769\u3092\u7d4c\u9a13\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305a\u3001\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u306e\u518d\u7de8\u304c\u52a0\u901f\u3057\u3066\u3044\u307e\u3059\u3002\u7c73\u4e2d\u8cbf\u6613\u6469\u64e6\u306e\u6fc0\u5316\u306b\u52a0\u3048\u3001EU\u304c\u63a8\u9032\u3059\u308b\u300c\u533b\u85ac\u6226\u75652030\u300d\u306b\u3088\u308a\u3001\u56fd\u5185\u306e\u80fd\u529b\u5f37\u5316\u304c\u4f53\u7cfb\u7684\u306b\u9032\u3081\u3089\u308c\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u7523\u696d\u30c1\u30a7\u30fc\u30f3\u304c\u5358\u4e00\u4f9b\u7d66\u6e90\u3078\u306e\u4f9d\u5b58\u304b\u3089\u8131\u5374\u3057\u3001\u591a\u69d8\u5316\u304c\u8feb\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u6b21\u306b\u3001AI\u99c6\u52d5\u578b\u306e\u30c9\u30e9\u30c3\u30b0\u30c7\u30b6\u30a4\u30f3\u3084\u5408\u6210\u751f\u7269\u5b66\u306a\u3069\u3001\u65b0\u305f\u306a\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u306e\u9769\u65b0\u304c\u7e70\u308a\u8fd4\u3057\u9032\u5c55\u3059\u308b\u3053\u3068\u3067\u3001\u6280\u8853\u9769\u547d\u304c\u6df1\u307e\u3063\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u65b0\u6280\u8853\u306f\u7814\u7a76\u958b\u767a\u3068\u751f\u7523\u306e\u30d1\u30e9\u30c0\u30a4\u30e0\u3092\u518d\u5f62\u6210\u3057\u3001\u30c7\u30b8\u30bf\u30eb\u5316\u3068\u30b9\u30de\u30fc\u30c8\u5316\u306e\u8ee2\u63db\u304c\u8ab2\u984c\u7a81\u7834\u306e\u9375\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u6700\u5f8c\u306b\u3001\u9700\u8981\u69cb\u9020\u304c\u5287\u7684\u306b\u5909\u5316\u3057\u3066\u304a\u308a\u3001\u65b0\u8208\u5e02\u5834\uff08\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u3001\u6771\u5357\u30a2\u30b8\u30a2\uff09\u306b\u304a\u3051\u308b\u533b\u85ac\u54c1\u6d88\u8cbb\u306e\u4f38\u3073\u304c\u3001\u6b27\u7c73\u6210\u719f\u5e02\u5834\u3092\u5927\u304d\u304f\u4e0a\u56de\u3063\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u3053\u3068\u306f\u3001\u4e2d\u56fd\u306e\u9769\u65b0\u7684\u306a\u533b\u85ac\u54c1\u3084\u533b\u7642\u6a5f\u5668\u306b\u3068\u3063\u3066\u65b0\u305f\u306a\u30d6\u30eb\u30fc\u30aa\u30fc\u30b7\u30e3\u30f3\u306e\u6249\u3092\u958b\u304f\u3053\u3068\u306b\u306a\u308a\u307e\u3059\u3002\u3053\u3046\u3057\u305f\u80cc\u666f\u306e\u3082\u3068\u30012025\u5e744\u670825\u65e5\u306e\u515a\u4e2d\u592e\u653f\u6cbb\u5c40\u4f1a\u8b70\u3067\u306f\u521d\u3081\u3066\u3001\u300c\u8cea\u306e\u9ad8\u3044\u767a\u5c55\u3068\u3044\u3046\u78ba\u5b9f\u6027\u3067\u5916\u90e8\u306e\u4e0d\u78ba\u5b9f\u6027\u306b\u5bfe\u6297\u3059\u308b\u300d\u3068\u3044\u3046\u65b9\u91dd\u304c\u63d0\u5531\u3055\u308c\u3001\u300c\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u4e3b\u5c0e\u3001\u591a\u89d2\u7684\u5354\u529b\u3001\u30ec\u30b8\u30ea\u30a8\u30f3\u30b9\u5f37\u5316\u306e\u57fa\u76e4\u300d\u3068\u3044\u3046\u7279\u5fb4\u3092\u6301\u3064\u3001\u9769\u65b0\u7684\u306a\u533b\u85ac\u54c1\u30fb\u533b\u7642\u6a5f\u5668\u8f38\u51fa\u306e\u767a\u5c55\u8def\u7dda\u304c\u63cf\u304b\u308c\u307e\u3057\u305f\u3002<\/p>\n
\u6226\u7565\u7684\u9752\u5199\u771f\u304b\u3089\u7523\u696d\u5b9f\u8df5\u3078\u306e\u4e09\u91cd\u306e\u30d6\u30ec\u30fc\u30af\u30b9\u30eb\u30fc<\/p>\n
\u7814\u7a76\u958b\u767a\uff1a\u4f8b\u3048\u3070\u3001\u30a4\u30f3\u30b0\u30b9\u30fb\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9\u304c\u72ec\u81ea\u958b\u767a\u3057\u305fChemistry42\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u5f37\u5316\u5b66\u7fd2\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0\u3092\u6d3b\u7528\u3057\u3066\u30ea\u30fc\u30c9\u5316\u5408\u7269\u306e\u6700\u9069\u5316\u30b5\u30a4\u30af\u30eb\u309278%\u304b\u30894\u304b\u6708\u306b\u77ed\u7e2e\u3057\u3001\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u3054\u3068\u306b3,000\u4e07\u5143\u4ee5\u4e0a\u306e\u7814\u7a76\u8cbb\u3092\u7bc0\u7d04\u3057\u307e\u3057\u305f\u3002\u4e00\u65b9\u3001\u6052\u745e\u533b\u85ac\u306e2025\u5e74\u7b2c1\u56db\u534a\u671f\u306e\u7814\u7a76\u958b\u767a\u8cbb\u306f15\u51043,300\u4e07\u5143\u306b\u9054\u3057\u3001\u3053\u308c\u307e\u3067\u306e\u7d2f\u8a08\u7814\u7a76\u6295\u8cc7\u984d\u306f460\u5104\u5143\u306b\u4e0a\u308a\u307e\u3059\u3002\u540c\u793e\u306f\u73fe\u5728\u300190\u7a2e\u985e\u4ee5\u4e0a\u306e\u81ea\u793e\u958b\u767a\u306e\u9769\u65b0\u7684\u306a\u88fd\u54c1\u304c\u81e8\u5e8a\u958b\u767a\u6bb5\u968e\u306b\u3042\u308a\u3001\u56fd\u5185\u5916\u3067\u7d04400\u4ef6\u306e\u6cbb\u9a13\u304c\u9032\u884c\u4e2d\u3067\u3059\u3002<\/p>\n
\u751f\u7523\uff1a\u4f8b\u3048\u3070\u3001\u63da\u5b50\u6c5f\u85ac\u696d\u30b0\u30eb\u30fc\u30d7\u306f\u3001AI\u3001\u30d3\u30c3\u30b0\u30c7\u30fc\u30bf\u3001\u30af\u30e9\u30a6\u30c9\u30b3\u30f3\u30d4\u30e5\u30fc\u30c6\u30a3\u30f3\u30b0\u306a\u3069\u6b21\u4e16\u4ee3\u60c5\u5831\u6280\u8853\u306e\u9769\u65b0\u7684\u306a\u6d3b\u7528\u3092\u7a4d\u6975\u7684\u306b\u9032\u3081\u3001\u683d\u57f9\u3001\u751f\u7523\u3001\u8f38\u9001\u306b\u81f3\u308b\u307e\u3067\u306e\u5168\u5de5\u7a0b\u3067\u30b9\u30de\u30fc\u30c8\u306a\u7ba1\u7406\u3092\u5b9f\u73fe\u3057\u3066\u3044\u307e\u3059\u3002\u30c7\u30b8\u30bf\u30eb\u30fb\u30b9\u30de\u30fc\u30c8\u5316\u306e\u30a2\u30c3\u30d7\u30b0\u30ec\u30fc\u30c9\u306b\u3088\u308a\u3001\u751f\u7523\u52b9\u7387\u304c28%\u5411\u4e0a\u3057\u3001\u751f\u7523\u91cf\u308243%\u5897\u52a0\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u3001\u5fa9\u661f\u8208\u9081\u306f\u91cd\u6176\u5e02\u306b7\u672c\u306eAI\u99c6\u52d5\u578b\u533b\u7642\u6a5f\u5668\u88fd\u54c1\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3092\u7acb\u3061\u4e0a\u3052\u308b\u8a08\u753b\u3092\u9032\u3081\u3001\u3053\u308c\u306b\u3088\u308a\u300c\u30b9\u30de\u30fc\u30c8\u30d8\u30eb\u30b9\u30b1\u30a2\u300d\u306e\u767a\u5c55\u3092\u652f\u63f4\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n
\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\uff1a\u4f8b\u3048\u3070\u3001\u4e5d\u5dde\u901a\u306e\u6f22\u65b9\u85ac\u30c8\u30ec\u30fc\u30b5\u30d3\u30ea\u30c6\u30a3\u30b7\u30b9\u30c6\u30e0\u306f\u3001\u30c7\u30b8\u30bf\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a9\u30fc\u30e1\u30fc\u30b7\u30e7\u30f3\u306e\u56fd\u5bb6\u30e2\u30c7\u30eb\u30b1\u30fc\u30b9\u3068\u3057\u3066\u8a8d\u5b9a\u3055\u308c\u307e\u3057\u305f\u3002\u307e\u305f\u3001\u540c\u793e\u306e\u30c7\u30b8\u30bf\u30eb\u533b\u7642\u30b5\u30d7\u30e9\u30a4\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u300c\u4e5d\u5dde\u4e07\u8fea\u30c7\u30b8\u30bf\u30eb\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u300d\u3084\u300c\u4e5d\u4fe1\u30b9\u30de\u30fc\u30c8\u6f22\u65b9\u85ac\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u300d\u306f\u3044\u305a\u308c\u3082\u56fd\u5bb6\u307e\u305f\u306f\u7701\u30ec\u30d9\u30eb\u306e\u6804\u8a89\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u4e00\u65b9\u3001\u83ef\u6d77\u85ac\u696d\u306f\u3001\u7c73\u56fd\u5e02\u5834\u306b\u304a\u3044\u3066\u76f4\u63a5\u8ca9\u58f2\u3001\u4e3b\u8981\u5378\u58f2\u696d\u8005\u3001\u5c0f\u58f2\u30c1\u30a7\u30fc\u30f3\u3001\u5546\u696d\u4f01\u696d\u306a\u3069\u591a\u69d8\u306a\u8ca9\u58f2\u30c1\u30e3\u30cd\u30eb\u4f53\u5236\u3092\u69cb\u7bc9\u3057\u307e\u3057\u305f\u3002\u540c\u793e\u306e\u8ca9\u58f2\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u306f\u7c73\u56fd\u306e\u5927\u90e8\u5206\u306e\u4e2d\u5c0f\u30fb\u5927\u624b\u533b\u85ac\u54c1\u8cfc\u5165\u696d\u8005\u3092\u30ab\u30d0\u30fc\u3057\u3001\u4e3b\u8981\u9867\u5ba2\u306f\u7c73\u56fd\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u533b\u85ac\u54c1\u5e02\u5834\u306e95%\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002<\/p>\n
\u4e00\u5e2f\u4e00\u8def\u30a4\u30cb\u30b7\u30a2\u30c6\u30a3\u30d6\u304c\u6210\u9577\u306e\u67f1\u3068\u3057\u3066\u6d6e\u4e0a\uff1a\u4e2d\u56fd\u533b\u85ac\u54c1\u8f38\u51fa\u5165\u5546\u4f1a\u304c\u307e\u3068\u3081\u305f\u7a0e\u95a2\u30c7\u30fc\u30bf\u306b\u3088\u308b\u3068\u30012025\u5e741\u6708\u304b\u30893\u6708\u307e\u3067\u306e\u9593\u306b\u3001\u30a2\u30e9\u30d6\u9023\u76df\uff0822\u30ab\u56fd\uff09\u5411\u3051\u306e\u8f38\u51fa\u984d\u306f\u524d\u5e74\u540c\u671f\u6bd410.21%\u5897\u306e10\u51048,000\u4e07\u4eba\u6c11\u5143\u306b\u9054\u3057\u307e\u3057\u305f\u3002<\/p>\n
\u5148\u9032\u5e02\u5834\u3078\u306e\u9032\u51fa\uff1a\u4f8b\u3048\u3070\u3001\u9e97\u73e0\u533b\u85ac\u306e\u30ed\u30c1\u30b4\u30c1\u30f3\u7d4c\u76ae\u30d1\u30c3\u30c1\u306f\u4eca\u5e74\u3001\u65e9\u671f\u304a\u3088\u3073\u5f8c\u671f\u306e\u7279\u767a\u6027\u30d1\u30fc\u30ad\u30f3\u30bd\u30f3\u75c5\u306e\u5146\u5019\u3068\u75c7\u72b6\u3001\u306a\u3089\u3073\u306b\u4e2d\u7b49\u5ea6\u304b\u3089\u91cd\u5ea6\u306e\u7279\u767a\u6027\u3080\u305a\u3080\u305a\u811a\u75c7\u5019\u7fa4\u306e\u6cbb\u7642\u3092\u76ee\u7684\u3068\u3057\u3066\u82f1\u56fd\u3067\u767a\u58f2\u3055\u308c\u307e\u3057\u305f\u3002\u3053\u306e\u88fd\u54c1\u306f\u82f1\u56fd\u3067\u767a\u58f2\u3055\u308c\u305f\u521d\u306eNeupro\u00ae\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u30d0\u30fc\u30b8\u30e7\u30f3\u3067\u3042\u308a\u3001Neupro\u00ae\u3068\u751f\u7269\u5b66\u7684\u540c\u7b49\u6027\u3092\u6709\u3057\u3066\u3044\u307e\u3059\u3002\u4e00\u65b9\u3001\u660e\u5fb3\u533b\u7642\u306e2024\u5e74\u7b2c3\u56db\u534a\u671f\u5831\u544a\u66f8\u306b\u3088\u308b\u3068\u3001\u540c\u793e\u306e\u533b\u7642\u753b\u50cf\u4e8b\u696d\u306f\u7b2c1\uff5e3\u56db\u534a\u671f\u306b\u524d\u5e74\u540c\u671f\u6bd411.4%\u5897\u306e59\u51047,000\u4e07\u5143\u306e\u53ce\u76ca\u3092\u4e0a\u3052\u3001\u305d\u306e\u3046\u3061\u30e8\u30fc\u30ed\u30c3\u30d1\u5e02\u5834\u306f30%\u4ee5\u4e0a\u6210\u9577\u3057\u307e\u3057\u305f\u3002<\/p>\n
3. \u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u306e\u30ec\u30b8\u30ea\u30a8\u30f3\u30b9\uff1a\u7523\u696d\u5b89\u5168\u4fdd\u969c\u306e\u57fa\u76e4\u7684\u8ad6\u7406\u3092\u5f37\u5316\u3059\u308b<\/p>\n
\u539f\u85ac\u306e\u9ad8\u5ea6\u5316\uff1a\u4e2d\u56fd\u306f\u5de5\u696d\u7528\u30da\u30cb\u30b7\u30ea\u30f3\u5869\u3001\u30d3\u30bf\u30df\u30f3\u3001\u30b5\u30eb\u30bf\u30f3\u4e2d\u9593\u4f53\u306e\u751f\u7523\u30fb\u4f9b\u7d66\u306b\u304a\u3044\u3066\u4e16\u754c\u5e02\u5834\u3067\u91cd\u8981\u306a\u5730\u4f4d\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u57fa\u76e4\u3092\u6d3b\u304b\u3057\u3064\u3064\u3001\u4eca\u5f8c\u306f\u9ad8\u4ed8\u52a0\u4fa1\u5024\u306e\u539f\u85ac\u4e2d\u9593\u4f53\u3078\u306e\u5c55\u958b\u3092\u52a0\u901f\u3055\u305b\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001\u30c8\u30f3\u30db\u30fc\u85ac\u696d\u306e\u30e1\u30b5\u30bf\u30be\u30fc\u30eb\u30ab\u30ea\u30a6\u30e0\u539f\u85ac\u306f\u97d3\u56fd\u306e\u85ac\u4e8b\u627f\u8a8d\u3092\u53d6\u5f97\u3057\u3001\u7c73\u56fd\u30fb\u30ab\u30ca\u30c0\u5411\u3051\u306e6\u4ef6\u306e\u7533\u8acb\u66f8\u985e\u306e\u63d0\u51fa\u3092\u5b8c\u4e86\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u3001\u4e5d\u5dde\u85ac\u696d\u306e\u8607\u5dde\u306b\u3042\u308b\u30da\u30d7\u30c1\u30c9\u539f\u85ac\u5de5\u5834\u306f2025\u5e74\u306b\u7b2c2\u30d5\u30a7\u30fc\u30ba\u306e\u5546\u696d\u751f\u7523\u8a2d\u5099\u5efa\u8a2d\u3092\u958b\u59cb\u3057\u30012025\u5e749\u6708\u306b\u306f\u751f\u7523\u3092\u59cb\u3081\u308b\u4e88\u5b9a\u3067\u3059\u3002\u3055\u3089\u306b\u30015\u5e74\u4ee5\u5185\u306b6\u672c\u306e\u30da\u30d7\u30c1\u30c9GMP\u751f\u7523\u30e9\u30a4\u30f3\u3092\u6574\u5099\u3057\u3001\u7c73\u56fd\u3068\u6b27\u5dde\u304c\u72ec\u5360\u3057\u3066\u3044\u308b\u72b6\u6cc1\u3092\u6253\u7834\u3059\u308b\u8a08\u753b\u3067\u3059\u3002<\/p>\n
\u5916\u90e8\u306e\u4e0d\u78ba\u5b9f\u6027\u3078\u306e\u5bfe\u51e6\uff1a<\/p>\n
3\u3064\u306e\u4e3b\u8981\u306a\u8ab2\u984c\u3068\u5bfe\u7b56\u306e\u7cbe\u5bc6\u306a\u6574\u5408\u6027<\/p>\n
1. \u8f38\u95a2\u7a0e\u969c\u58c1\u3068\u6280\u8853\u5c01\u9396\uff1a\u300c\u30b3\u30b9\u30c8\u7af6\u4e89\u300d\u304b\u3089\u300c\u4fa1\u5024\u306e\u30d6\u30ec\u30fc\u30af\u30b9\u30eb\u30fc\u300d\u3078<\/p>\n
2. \u56fd\u969b\u7684\u306a\u898f\u5236\u9075\u5b88\uff1a\u300c\u53d7\u52d5\u7684\u9069\u5fdc\u300d\u304b\u3089\u300c\u30eb\u30fc\u30eb\u306e\u5171\u5275\u300d\u3078<\/p>\n
Premium Product Portfolio: Avoiding low-value-added \u201cred ocean\u201d products by focusing on emerging fields like biologics and cell therapies. For instance, CAR-T therapy production technologies (e.g., Legend Biotech\u2019s CARVYKTI\u00ae) involve complex gene editing and cell culture processes, commanding higher value.<\/p>\n
Leveraging Regional Free Trade Agreements: Facing U.S. market policy uncertainties, Chinese enterprises are adjusting strategies\u2014particularly by accelerating Southeast Asian market expansion under RCEP origin accumulation rules while simultaneously building operations in emerging markets like Europe, the Middle East, and Latin America. Through regulatory approvals, channel development, and brand promotion, they are constructing more balanced global sales networks to effectively diversify operational risks.<\/p>\n
[QWEN_MT_ITEM_1]\u4f1d\u7d71\u4e2d\u56fd\u533b\u85ac\u306e\u56fd\u969b\u6a19\u6e96\u5316\u306b\u304a\u3051\u308b\u753b\u671f\u7684\u306a\u9032\u5c55\uff1a\u4e2d\u56fd\u4e2d\u533b\u79d1\u5b66\u9662\u3068\u5e83\u897f\u85ac\u7528\u690d\u7269\u5712\u304c\u30e9\u30aa\u30b9\u3068\u306e\u5354\u529b\u306e\u3082\u3068\u3001\u540c\u56fd\u306e\u85ac\u5c40\u65b9\u4f5c\u6210\u3092\u652f\u63f4\u3057\u305f\u4e8b\u4f8b\u3092\u898b\u308b\u3068\u3001\u3053\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306f\u73fe\u5730\u306e\u85ac\u8349\u6587\u5316\u3092\u5c0a\u91cd\u3059\u308b\u3068\u3068\u3082\u306b\u3001\u4e2d\u56fd\u306e\u5b9f\u8df5\u7684\u7d4c\u9a13\u3082\u5171\u6709\u3057\u3066\u3044\u307e\u3059\u3002\u6771\u5357\u30a2\u30b8\u30a2\u3084\u4e2d\u7c73\u3067\u306f\u3001\u4e00\u90e8\u306e\u56fd\u3005\u304c\u5b9f\u52d9\u4e0a\u306e\u30cb\u30fc\u30ba\u306b\u57fa\u3065\u304d\u3001\u4e2d\u56fd\u85ac\u5c40\u65b9\u306b\u63b2\u8f09\u3055\u308c\u3066\u3044\u308b\u7279\u5b9a\u306e\u4f1d\u7d71\u4e2d\u56fd\u533b\u85ac\u54c1\u7a2e\u306b\u95a2\u3059\u308b\u57fa\u6e96\u3092\u53c2\u8003\u3057\u59cb\u3081\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u30ab\u30ca\u30c0\u5f53\u5c40\u306f\u7a4d\u6975\u7684\u306b\u95a2\u4e0e\u3057\u3001\u4e2d\u56fd\u85ac\u5c40\u65b9\u7b2c1\u5dfb\u306b\u53ce\u9332\u3055\u308c\u305f\u4e2d\u56fd\u7523\u85ac\u7528\u690d\u7269\u7a2e\u306e\u8a8d\u77e5\u5ea6\u5411\u4e0a\u3092\u63a8\u9032\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u52d5\u304d\u306f\u3001\u4e2d\u56fd\u306e\u533b\u85ac\u54c1\u57fa\u6e96\u306b\u5bfe\u3059\u308b\u56fd\u969b\u7684\u306a\u8a55\u4fa1\u3092\u53cd\u6620\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n
Building Full-Process Compliance Capabilities: For instance, WuXi AppTec\u2019s two active pharmaceutical ingredient (API) manufacturing sites in Changzhou and Taixing, Jiangsu Province, both successfully passed U.S. Food and Drug Administration (FDA) inspections in March this year with zero defects. The FDA did not issue any Form 483 (inspection findings report).<\/p>\n
For instance, as of April 2025, Ascentage Pharma holds 541 authorized patents, including 379 overseas patents covering major global markets. Hengrui Medicine has filed 45 international patents in the PD-1 monoclonal antibody field, with its drug Camrelizumab entering markets like Turkey and Egypt through a \u201cpatent licensing + localized production\u201d model.<\/p>\n
Policy synergy: The Implementation Plan for the Major Project of Revitalization and Development of Traditional Chinese Medicine<\/em> specifies that during the 14th Five-Year Plan period, 50 overseas TCM centers will be established and 50 international standards will be released. The Ministry of Commerce\u2019s \u201cTCM Service Export Bases\u201d have already covered 32 countries, serving more than 2 million people annually.<\/p>\n Technology-driven innovation: For example, Yunnan Baiyao has applied \u201cphytochemistry-based metabolomics + network pharmacology\u201d technology to increase the purity of the active ingredient Panax notoginseng saponins to 98%, thereby overcoming the EU\u2019s \u201ccontent uniformity\u201d barrier for herbal medicine registration.<\/p>\n Rise of dual-headquarter models: For instance, BeiGene has established R centers in both China and the United States, conducting international multi-center Phase III clinical trials in parallel, achieving a \u201cShanghai by day, Boston by night\u201d 24-hour relay R model. Similarly, Zai Lab has set up a translational medicine center in London to quickly access European clinical trial resources.<\/p>\n Cross-border innovation ecosystems: For example, Suzhou BioBAY has established offshore innovation centers in Singapore and Boston, creating a closed-loop model of \u201cR overseas, translation in Suzhou, globalized markets.\u201d It has already incubated more than 10 enterprises, including Innovent Biologics and Keymed Biosciences.<\/p>\n \u30cf\u30eb\u30d3\u30f3\u85ac\u54c1\u30b0\u30eb\u30fc\u30d7\uff08\u30cf\u30a4\u30e4\u30aa\uff09\uff1a2025\u5e74\u306e Quality and Efficiency Enhancement with Sustainable Returns<\/em> action plan, the company proposed to build a green industrial chain through digital-intelligent production and cost control. In April, Hayao\u2019s subsidiary Sanjing Pharmaceutical signed an agreement with Jiuzhou Group for a distributed photovoltaic project in the Daqing Glass Industrial Park, aiming to accelerate its low-carbon transformation through solar power generation.<\/p>\n Qilu Pharmaceutical (Hainan) Co., Ltd.: Using the Qilu Pharmaceutical Integrated Energy Management Platform, its production workshop employs a three-stage heat exchange freeze dryer, saving over 200,000 kWh of electricity per unit annually. Meanwhile, its purified water preparation system has been upgraded with concentrated water recycling, raising the recovery rate to 90% and saving more than 10,000 tons of water annually.<\/p>\n By consolidating innovation engines through digital-intelligent transformation, diversifying markets to spread risks, and strengthening supply chain resilience against shocks, China\u2019s innovative pharmaceuticals and medical devices are shaping the \u201cthree certainties\u201d of high-quality development to counter the \u201cthree uncertainties\u201d of global industrial chain restructuring.<\/p>\n Facing multiple challenges of \u201ctariff pressure + technological blockades + regulatory reshaping,\u201d China\u2019s pharmaceutical exports are shifting from \u201cfactor-driven\u201d to \u201cefficiency-driven\u201d and \u201cinnovation-driven.\u201d At the government level, it is necessary to accelerate the formulation of international TCM standards and improve policy toolkits for digital-intelligent transformation. At the enterprise level, companies should build resilient systems of \u201cglobalized R, localized production, and diversified markets.\u201d At the industry level, it is essential to leverage new platforms such as free trade zones and cross-border innovation ecosystems to explore integrated export models of \u201cmedicine + services\u201d and \u201cproducts + technology.\u201d<\/p>\n Going forward, only by rooting the \u201ccertainty\u201d of high-quality development in innovation capacity, industrial resilience, and global collaboration can China firmly seize the strategic initiative of pharmaceutical and medical device internationalization amidst unprecedented global changes, contributing a \u201cChina Solution\u201d to the global health industry chain.<\/p>\n <\/p>","protected":false},"excerpt":{"rendered":" \u73fe\u5728\u3001\u4e16\u754c\u306e\u88fd\u85ac\u696d\u754c\u306f3\u3064\u306e\u5927\u304d\u306a\u5909\u9769\u671f\u3092\u8fce\u3048\u3066\u3044\u308b\uff1a\u7b2c\u4e00\u306b\u3001\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u306e\u518d\u7de8\u304c\u52a0\u901f\u3057\u3066\u3044\u308b\u3002\u7b2c\u4e00\u306b\u3001\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u306e\u518d\u69cb\u7bc9\u304c\u52a0\u901f\u3057\u3066\u3044\u308b\u3002\u4e2d\u7c73\u8cbf\u6613\u6469\u64e6\u306e\u6fc0\u5316\u3068\u3001EU\u306e\u300c\u533b\u85ac\u54c1\u6226\u75652030\u300d\u304c\u56fd\u5185\u306e\u80fd\u529b\u69cb\u7bc9\u3092\u7d44\u7e54\u7684\u306b\u63a8\u9032\u3057\u3066\u3044\u308b\u3053\u3068\u304c\u76f8\u307e\u3063\u3066\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u7523\u696d\u30c1\u30a7\u30fc\u30f3\u306f\u5358\u4e00\u30bd\u30fc\u30b9\u3078\u306e\u4f9d\u5b58\u304b\u3089\u8131\u5374\u3059\u308b\u305f\u3081\u306e\u591a\u69d8\u5316\u3092\u4f59\u5100\u306a\u304f\u3055\u308c\u3066\u3044\u308b\u3002\u7b2c\u4e8c\u306b\u3001\u6280\u8853\u9769\u547d\u306f\u53cd\u5fa9\u7684\u306a\u9032\u6b69\u3092\u901a\u3058\u3066\u6df1\u5316\u3057\u3066\u3044\u308b\u3002AI\u3092\u99c6\u4f7f\u3057\u305f\u85ac\u5264\u8a2d\u8a08\u3084\u5408\u6210\u751f\u7269\u5b66\u306a\u3069\u306e\u65b0\u6280\u8853\u306f\u3001\u7814\u7a76\u958b\u767a\u3084\u751f\u7523\u306e\u30d1\u30e9\u30c0\u30a4\u30e0\u3092\u518d\u69cb\u7bc9\u3057\u3066\u304a\u308a\u3001\u30c7\u30b8\u30bf\u30eb\u3067\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30c8\u306a\u5909\u9769\u304c\u8ab2\u984c\u6253\u958b\u306e\u30ab\u30ae\u3068\u306a\u3063\u3066\u3044\u308b\u3002\u7b2c\u4e09\u306b\u3001\u9700\u8981\u69cb\u9020\u304c\u5287\u7684\u306b\u5909\u5316\u3057\u3066\u304a\u308a\u3001\u65b0\u8208\u5e02\u5834\uff08\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u3001\u6771\u5357\u30a2\u30b8\u30a2\uff09\u306e\u533b\u85ac\u54c1\u6d88\u8cbb\u306e\u4f38\u3073\u304c\u6b27\u7c73\u306e\u6210\u719f\u5e02\u5834\u3092\u5927\u304d\u304f\u4e0a\u56de\u3063\u3066\u3044\u308b\u3002<\/p>","protected":false},"author":4,"featured_media":655,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[62],"tags":[],"class_list":["post-654","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry-dynamics"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.medicalsoho.com\/ja\/wp-json\/wp\/v2\/posts\/654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.medicalsoho.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.medicalsoho.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.medicalsoho.com\/ja\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.medicalsoho.com\/ja\/wp-json\/wp\/v2\/comments?post=654"}],"version-history":[{"count":0,"href":"https:\/\/www.medicalsoho.com\/ja\/wp-json\/wp\/v2\/posts\/654\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.medicalsoho.com\/ja\/wp-json\/wp\/v2\/media\/655"}],"wp:attachment":[{"href":"https:\/\/www.medicalsoho.com\/ja\/wp-json\/wp\/v2\/media?parent=654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.medicalsoho.com\/ja\/wp-json\/wp\/v2\/categories?post=654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.medicalsoho.com\/ja\/wp-json\/wp\/v2\/tags?post=654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}2. Global R Networks: From \u201cLocal Enterprises\u201d to \u201cMultinational Companies\u201d<\/h3>\n
3. Green and Low-Carbon Transition: A New Threshold for Global Competition<\/h3>\n
Conclusion: Building New Advantages through Dynamic Balance<\/h2>\n